Srgap1 Gene Thyroid Cancer Type 2 Nonmedullary Susceptibility to NGS Genetic DNA Test
Introduction
The Srgap1 Gene Thyroid Cancer Type 2 Nonmedullary Susceptibility to NGS Genetic DNA Test is an advanced diagnostic tool designed to assess the genetic predisposition to thyroid cancer. This test is particularly important for individuals with a family history of thyroid cancer, as it provides critical insights that can guide preventive measures and treatment options.
What the Test Measures
This genetic test utilizes Next Generation Sequencing (NGS) technology to analyze the SRGAP1 gene, which has been associated with nonmedullary thyroid cancer susceptibility. By detecting specific mutations or alterations in this gene, healthcare providers can better understand an individual’s risk of developing this type of cancer.
Who Should Consider This Test
Individuals who should consider undergoing the Srgap1 Gene Thyroid Cancer Type 2 Nonmedullary Susceptibility to NGS Genetic DNA Test include:
- Those with a family history of thyroid cancer.
- Individuals experiencing symptoms such as lumps in the neck, difficulty swallowing, or unexplained weight changes.
- People with known genetic predispositions to cancer.
Benefits of Taking the Test
Taking the Srgap1 Gene Thyroid Cancer Type 2 Nonmedullary Susceptibility to NGS Genetic DNA Test offers several benefits:
- Early detection of genetic predispositions can lead to proactive monitoring and management.
- Informed decision-making regarding lifestyle changes and preventive measures.
- Guidance for family members who may also be at risk.
Understanding Your Results
Results from the test will provide insight into whether any mutations in the SRGAP1 gene are present. It is important to discuss these results with a genetic counselor or healthcare provider who can help interpret the findings and recommend appropriate follow-up actions.
Test Pricing
| Test Name | Discount Price (NGN) | Regular Price (NGN) |
|---|---|---|
| Srgap1 Gene Thyroid Cancer Type 2 Nonmedullary Susceptibility to NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Book the Test
Ready to take control of your health? Book the Srgap1 Gene Thyroid Cancer Type 2 Nonmedullary Susceptibility to NGS Genetic DNA Test today! For more information or to schedule your appointment, call or WhatsApp us at +2348077798758.
Additional Information
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-Test Instructions: Clinical history of the patient going for the test, along with a genetic counseling session to draw a pedigree chart of family members affected with the SRGAP1 gene.
Specialty: Oncologist
Department: Genetics
Method: NGS Technology
Disease Type: Cancer
